A. Pehlivanidis

1.3k total citations
15 papers, 948 citations indexed

About

A. Pehlivanidis is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Pehlivanidis has authored 15 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Pehlivanidis's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A. Pehlivanidis is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A. Pehlivanidis collaborates with scholars based in Greece, United Kingdom and United States. A. Pehlivanidis's co-authors include Athanasios A. Papageorgiou, Vasilios G. Athyros, Athanasios N. Symeonidis, Vasilios I. Bouloukos, Moses Elisaf, D. P. Mikhailidis, Athanasios G. Kontopoulos, Dimokritos S. Demitriadis, Dimitri P. Mikhailidis and Haralambos Milionis and has published in prestigious journals such as American Journal of Kidney Diseases, Journal of Clinical Pathology and Atherosclerosis.

In The Last Decade

A. Pehlivanidis

14 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Pehlivanidis Greece 12 491 363 310 202 161 15 948
D. P. Mikhailidis United Kingdom 12 457 0.9× 376 1.0× 227 0.7× 195 1.0× 148 0.9× 22 896
Vasilios I. Bouloukos Greece 8 398 0.8× 315 0.9× 194 0.6× 201 1.0× 138 0.9× 8 749
Athanasios N. Symeonidis Greece 12 775 1.6× 501 1.4× 354 1.1× 219 1.1× 195 1.2× 16 1.3k
Farhad Zangeneh United States 10 491 1.0× 452 1.2× 250 0.8× 70 0.3× 86 0.5× 17 994
Marcin Barylski Poland 16 308 0.6× 207 0.6× 451 1.5× 139 0.7× 149 0.9× 80 1.1k
Roland E. Schmieder Germany 16 404 0.8× 326 0.9× 806 2.6× 295 1.5× 83 0.5× 33 1.4k
Arihiro Kiyosue Japan 19 486 1.0× 507 1.4× 274 0.9× 147 0.7× 110 0.7× 72 1.2k
Jean-Claude Ansquer France 16 398 0.8× 488 1.3× 203 0.7× 261 1.3× 123 0.8× 30 1.3k
Carlo M. Barbagallo Italy 22 747 1.5× 503 1.4× 580 1.9× 72 0.4× 181 1.1× 100 1.6k
B L Kasiske United States 13 456 0.9× 191 0.5× 180 0.6× 264 1.3× 109 0.7× 16 1.3k

Countries citing papers authored by A. Pehlivanidis

Since Specialization
Citations

This map shows the geographic impact of A. Pehlivanidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pehlivanidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pehlivanidis more than expected).

Fields of papers citing papers by A. Pehlivanidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pehlivanidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pehlivanidis. The network helps show where A. Pehlivanidis may publish in the future.

Co-authorship network of co-authors of A. Pehlivanidis

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pehlivanidis. A scholar is included among the top collaborators of A. Pehlivanidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pehlivanidis. A. Pehlivanidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pehlivanidis, A., et al.. (2024). Major Systemic Lupus Erythematosus Exacerbation after Severe Clostridium Difficile Infection: A Case Report. Mediterranean Journal of Rheumatology. 35(4). 684–684.
2.
Kouklakis, Georgios, Petros Zezos, John Moschos, et al.. (2007). Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole. Annals of Hepatology. 6(1). 63–65. 18 indexed citations
3.
Athyros, Vasilios G., Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, et al.. (2005). Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease.A subgroup analysis of the GREACE study. Platelets. 16(2). 65–71. 13 indexed citations
4.
Athyros, Vasilios G., Moses Elisaf, Athanasios A. Papageorgiou, et al.. (2004). Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study. American Journal of Kidney Diseases. 43(4). 589–599. 159 indexed citations
5.
Athyros, Vasilios G., Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, et al.. (2004). Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Current Medical Research and Opinion. 20(5). 627–637. 51 indexed citations
6.
Athyros, Vasilios G., Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, et al.. (2004). Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Current Medical Research and Opinion. 20(9). 1385–1392. 11 indexed citations
7.
Athyros, Vasilios G., D. P. Mikhailidis, Athanasios A. Papageorgiou, et al.. (2004). The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. Journal of Clinical Pathology. 57(7). 728–734. 257 indexed citations
8.
Athyros, Vasilios G., D. P. Mikhailidis, Athanasios A. Papageorgiou, et al.. (2004). Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease. Journal of Human Hypertension. 18(11). 781–788. 53 indexed citations
9.
Athyros, Vasilios G., Vasilios I. Bouloukos, A. Pehlivanidis, et al.. (2004). The prevalence of the metabolic syndrome in Greece: The MetS‐Greece Multicentre Study. Diabetes Obesity and Metabolism. 7(4). 397–405. 141 indexed citations
10.
Athyros, Vasilios G., et al.. (2004). W09.203 The prevalence of the metabolic syndrome in Greece: The MetS-Greece study. Atherosclerosis Supplements. 5(1). 47–47. 1 indexed citations
11.
Kontopoulos, Athanasios G., Vasilios G. Athyros, A. Pehlivanidis, et al.. (2003). Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Current Medical Research and Opinion. 19(1). 22–27. 48 indexed citations
12.
Athyros, Vasilios G., Athanasios A. Papageorgiou, Athanasios N. Symeonidis, et al.. (2003). Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus. Angiology. 54(6). 679–690. 64 indexed citations
13.
Athyros, Vasilios G., Athanasios A. Papageorgiou, Valasia V. Athyrou, et al.. (2002). Atorvastatin versus Four Statin-Fibrate Combinations in Patients with Familial Combined Hyperlipidaemia. European Journal of Cardiovascular Prevention & Rehabilitation. 9(1). 33–39. 32 indexed citations
14.
Athyros, Vasilios G., Athanasios A. Papageorgiou, Valasia V. Athyrou, et al.. (2002). . Journal of Cardiovascular Risk. 9(1). 33–39. 18 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. P. Mikhailidis Breakdown of academic impact, for papers by Vasilios I. Bouloukos Breakdown of academic impact, for papers by Athanasios N. Symeonidis Breakdown of academic impact, for papers by Farhad Zangeneh Breakdown of academic impact, for papers by Marcin Barylski Breakdown of academic impact, for papers by Roland E. Schmieder Breakdown of academic impact, for papers by Arihiro Kiyosue Breakdown of academic impact, for papers by Jean-Claude Ansquer Breakdown of academic impact, for papers by Carlo M. Barbagallo Breakdown of academic impact, for papers by B L Kasiske
Rankless by CCL
2026